Latest filing published 29 May 2026 for Edesa Biotech, Inc..
No signal scores available.
Da David Liu discloses dealings in Edesa Biotech, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 29 May 2025 and the latest from 27 May 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 29 May 2026 came the latest disclosure, a share grant in Edesa Biotech, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations